arrow
M

Mechthild Krause

university hospital carl gustav carus
H指数:63
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients

WHO-2型脑膜瘤手术辅助分次放射治疗的疗效比较:一项包含1,452例患者的多中心回顾性队列研究(分为全切除与非全切除两组)

2026-02-090
OAAI
Radiation Oncology Representation in German Evidence-Based Oncological Guidelines: 2025 Analysis of Participation and Parity from Women in Radiation Oncology Working Group of the German Society of Radiation Oncology (DEGRO)

德国循证肿瘤学指南中放射肿瘤学的代表性:德国放射肿瘤学会(DEGRO)放射肿瘤学女性工作组2025年关于参与度和性别平等的分析

2025-12-100
PRE
Strahlenschutzrechtliche Verfahren im Kontext des neuen Medizinforschungsgesetzes: Was ändert sich, was bleibt? Ein gemeinsamer Überblick von der Deutschen Gesellschaft für Radioonkologie (DEGRO) und dem Bundesamt für Strahlenschutz (BfS)

在新《医学研究法》背景下的放射防护程序:有哪些变化,哪些保持不变?德国放射肿瘤学会(DEGRO)和联邦辐射防护局(BfS)联合概述

2025-11-200
OAAI
Application of a preclinical 18-gene classifier to patients with locally advanced HNSCC

将一种预临床18基因分类器应用于局部晚期HNSCC患者

2025-11-050
OAAI
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors

ESMO-ESTRO关于将放射疗法与免疫检查点抑制剂、VEGF(R)抑制剂或多靶点酪氨酸激酶抑制剂联合使用的安全性共识声明

2025-09-260
PRE
Accelerated vs. conventionally fractionated postoperative radiotherapy of non-small cell lung cancer—final results of the prematurely terminated PORTAF trial

加速对比常规分割术后放疗治疗非小细胞肺癌——PORTAF试验提前终止的最终结果

2025-07-150
OAAI
Total lesion Glycolysis of primary tumor and lymphnodes is a strong predictor for development of distant metastases in oropharyngeal carcinoma patients with independent validation in automatically delineated lesions (vol 25, 18, 2025)
2025-04-070
OAAI
Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism

基于血液检测MMP11作为由ALDH1A1-TGF-β1信号机制调控的前列腺癌进展标志物

2025-03-240
OA
Tumor Asphericity in FDG PET Is an Independent Prognostic Parameter Improving Risk Stratification in Patients with Head and Neck Squamous Cell Carcinoma

FDG PET中的肿瘤球状度是头颈部鳞状细胞癌患者独立的不良预后参数,可改善风险分层。

2025-03-130
PRE
Total lesion glycolysis of primary tumor and lymphnodes is a strong predictor for development of distant metastases in oropharyngeal carcinoma patients with independent validation in automatically delineated lesions
2025-02-210
OAAI
Variable-RBE-induced NTCP predictions for various side-effects following proton therapy for brain tumors - Identification of high-risk patients and risk mitigation

质子治疗脑肿瘤后各种副作用的可变RBE诱导的NTCP预测-高危患者的识别和风险缓解

2025-01-010
OAAI
Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A report from the European Society for Pediatric Oncology DIPG/DMG Registry

使用历史队列研究弥漫性内在性脑桥胶质瘤的治疗相关生存模式: 来自欧洲儿科肿瘤学会DIPG/DMG登记处的报告

2024-09-100
OAAI
A deep-learning-based surrogate model for Monte-Carlo simulations of the linear energy transfer in primary brain tumor patients treated with proton-beam radiotherapy

基于深度学习的替代模型,用于对接受质子束放射治疗的原发性脑肿瘤患者的线性能量转移进行蒙特卡洛模拟

2024-08-120
OA
Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [11C] methionine PET and T1c-w MRI

基于术后 [11C] 蛋氨酸PET和T1c-w MRI的新诊断胶质母细胞瘤残留肿瘤检测和预后的影像组学研究

2024-02-252
OAAI